The effects of weight loss using dietary manipulation and rimonabant therapy on arterial stiffness in type 2 diabetes

Artery Research

Volumn 4, Issue 2, 2010, Pages 47-51

  Chakera, A ^a   Bunce, S ^a   Heppenstall, C ^a   Smith, J C ^a  

^a TORBAY HOSPITAL   (United Kingdom)

Author keywords

Arterial stiffness; Diabetes; Obesity

Indexed keywords

HEMOGLOBIN A1C; RIMONABANT;

ADULT; AGED; AORTA PRESSURE; ARTERIAL STIFFNESS; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DRUG WITHDRAWAL; FEMALE; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; MEAN ARTERIAL PRESSURE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PULSE WAVE; TREATMENT DURATION; WEIGHT REDUCTION;

EID: 77954660042     PISSN: 18729312     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.artres.2010.04.001     Document Type: Article

References (22)

1. Stehouwer C.D., Henry R.M., Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 2008, 51:527-539.
2. Hansen T.W., Staessen J.A., Torp-Pedersen C., Rasmussen S., Thijs L., Ibsen H., et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006, 113:664-670.
3. Laurent S., Katsahian S., Fassot C., Tropeano A.I., Gautier I., Laloux B., et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003, 34:1203-1206.
4. Blacher J., Safar M.E., Guerin A.P., Pannier B., Marchais S.J., London G.M. Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 2003, 63:1852-1860.
5. Cruickshank K., Riste L., Anderson S.G., Wright J.S., Dunn G., Gosling R.G. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?. Circulation 2002, 106:2085-2090.
6. Roman M.J., Devereux R.B., Kizer J.R., Lee E.T., Galloway J.M., Ali T., et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007, 50:197-203.
7. Sharman J.E., Fang Z.Y., Haluska B., Stowasser M., Prins J.B., Marwick T.H. Left ventricular mass in patients with type 2 diabetes is independently associated with central but not peripheral pulse pressure. Diabetes Care 2005, 28:937-939.
8. Sutton-Tyrrell K., Newman A., Simonsick E.M., Havlik R., Pahor M., Lakatta E., et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension 2001, 38:429-433.
9. Wildman R.P., Mackey R.H., Bostom A., Thompson T., Sutton-Tyrrell K. Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension 2003, 42:468-473.
10. Scheen A.J., Finer N., Hollander P., Jensen M.D., Van Gaal L.F. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet 2006, 368:1660-1672. RIO-Diabetes Study Group.
11. Howlett A.C., Breivogel C.S., Childers S.R., Deadwyler S.A., Hampson R.E., Porrino L.J. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 2004, 47(Suppl. 1):345-358.
12. Pacher P., Bátkai S., Kunos G. Blood pressure regulation by endocannabinoids and their receptors. Neuropharmacology 2005, 48:1130-1138.
13. O'Rourke M.F., Gallagher D.E. Pulse wave analysis. J Hypertens 1996, 14(Suppl. 5):S147-S157.
14. Pauca A.L., O'Rourke M.F., Kon N.D. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001, 38:932-937.
15. Wilkinson I.B., Fuchs S.A., Jansen I.M., Spratt J.C., Murray G.D., Cockcroft J.R., et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998, 16:2079-2084.
16. Goldberg Y., Boaz M., Matas Z., Goldberg I., Shargorodsky M. Weight loss induced by nutritional and exercise intervention decreases arterial stiffness in obese subjects. Clin Nutr 2009, 28:21-25.
17. Aizawa K., Shoemaker J.K., Overend T.J., Petrella R.J. Effects of lifestyle modification on central artery stiffness in metabolic syndrome subjects with pre-hypertension and/or pre-diabetes. Diabetes Res Clin Pract 2009, 83:249-256.
18. Barinas-Mitchell E., Kuller L.H., Sutton-Tyrrell K., Hegazi R., Harper P., Mancino J., et al. Effect of weight loss and nutritional intervention on arterial stiffness in type 2 diabetes. Diabetes Care 2006, 29:2218-2222.
19. Mendizábal V.E., Adler-Graschinsky E. Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions. Br J Pharmacol 2007, 151:427-440.
20. Bátkai S., Pacher P., Osei-Hyiaman D., Radaeva S., Liu J., Harvey-White J., et al. Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation 2004, 110:1996-2002.
21. Benowitz N.L., Jones R.T. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin Pharmacol Ther 1975, 18:287-297.
22. Nissen S.E., Nicholls S.J., Wolski K., Rodés-Cabau J., Cannon C.P., Deanfield J.E., et al. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. JAMA 2008, 299:1547-1560.